Redsense Medical AB Statistics
Total Valuation
RDSNF has a market cap or net worth of 10.11 million. The enterprise value is 8.53 million.
| Market Cap | 10.11M |
| Enterprise Value | 8.53M |
Important Dates
The next estimated earnings date is Tuesday, May 6, 2025.
| Earnings Date | May 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +21.25% |
| Shares Change (QoQ) | +0.67% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 6.64M |
Valuation Ratios
The trailing PE ratio is 327.17.
| PE Ratio | 327.17 |
| Forward PE | n/a |
| PS Ratio | 3.89 |
| PB Ratio | 2.83 |
| P/TBV Ratio | 2.83 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 16.33, with an EV/FCF ratio of -11.44.
| EV / Earnings | 275.91 |
| EV / Sales | 2.87 |
| EV / EBITDA | 16.33 |
| EV / EBIT | n/a |
| EV / FCF | -11.44 |
Financial Position
The company has a current ratio of 12.65
| Current Ratio | 12.65 |
| Quick Ratio | 9.79 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 1.09% and return on invested capital (ROIC) is 0.42%.
| Return on Equity (ROE) | 1.09% |
| Return on Assets (ROA) | 0.38% |
| Return on Invested Capital (ROIC) | 0.42% |
| Return on Capital Employed (ROCE) | 0.53% |
| Revenue Per Employee | 519,909 |
| Profits Per Employee | 6,180 |
| Employee Count | 5 |
| Asset Turnover | 0.84 |
| Inventory Turnover | 2.91 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | 0.55 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | n/a |
| Average Volume (20 Days) | 229 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, RDSNF had revenue of 2.60 million and earned 30,902 in profits. Earnings per share was 0.00.
| Revenue | 2.60M |
| Gross Profit | 1.63M |
| Operating Income | 18,884 |
| Pretax Income | 30,902 |
| Net Income | 30,902 |
| EBITDA | 457,292 |
| EBIT | 18,884 |
| Earnings Per Share (EPS) | 0.00 |
Balance Sheet
The company has 1.39 million in cash and n/a in debt, giving a net cash position of 1.39 million.
| Cash & Cash Equivalents | 1.39M |
| Total Debt | n/a |
| Net Cash | 1.39M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 3.58M |
| Book Value Per Share | 0.22 |
| Working Capital | 2.33M |
Cash Flow
In the last 12 months, operating cash flow was -743,540 and capital expenditures -1,536, giving a free cash flow of -745,076.
| Operating Cash Flow | -743,540 |
| Capital Expenditures | -1,536 |
| Free Cash Flow | -745,076 |
| FCF Per Share | n/a |
Margins
Gross margin is 62.83%, with operating and profit margins of 0.73% and 1.19%.
| Gross Margin | 62.83% |
| Operating Margin | 0.73% |
| Pretax Margin | 1.19% |
| Profit Margin | 1.19% |
| EBITDA Margin | 17.59% |
| EBIT Margin | 0.73% |
| FCF Margin | n/a |
Dividends & Yields
RDSNF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -21.25% |
| Shareholder Yield | -21.25% |
| Earnings Yield | 0.31% |
| FCF Yield | -7.37% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
RDSNF has an Altman Z-Score of 30.72.
| Altman Z-Score | 30.72 |
| Piotroski F-Score | n/a |